Scott A. Kelly - Net Worth and Insider Trading

Scott A. Kelly Net Worth

The estimated net worth of Scott A. Kelly is at least $285,965 dollars as of 2024-11-13. Scott A. Kelly is the Chief Medical Officer of CytoDyn Inc and owns about 2,280,240 shares of CytoDyn Inc (CYDY) stock worth over $285,965. Details can be seen in Scott A. Kelly's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Scott A. Kelly has not made any transactions after 2020-05-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Scott A. Kelly

To

Scott A. Kelly Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Scott A. Kelly owns 1 companies in total, including CytoDyn Inc (CYDY) .

Click here to see the complete history of Scott A. Kelly’s form 4 insider trades.

Insider Ownership Summary of Scott A. Kelly

Ticker Comapny Transaction Date Type of Owner
CYDY CytoDyn Inc 2020-05-01 director

Scott A. Kelly Latest Holdings Summary

Scott A. Kelly currently owns a total of 1 stock. Scott A. Kelly owns 2,280,240 shares of CytoDyn Inc (CYDY) as of May 1, 2020, with a value of $285,965.

Latest Holdings of Scott A. Kelly

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CYDY CytoDyn Inc 2020-05-01 2,280,240 0.13 285,965

Holding Weightings of Scott A. Kelly


Scott A. Kelly Form 4 Trading Tracker

According to the SEC Form 4 filings, Scott A. Kelly has made a total of 3 transactions in CytoDyn Inc (CYDY) over the past 5 years, including 1 buys and 2 sells. The most-recent trade in CytoDyn Inc is the sale of 1,200,000 shares on May 1, 2020, which brought Scott A. Kelly around $4 Million.

Insider Trading History of Scott A. Kelly

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Scott A. Kelly Trading Performance

GuruFocus tracks the stock performance after each of Scott A. Kelly's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Scott A. Kelly is 55.68%. GuruFocus also compares Scott A. Kelly's trading performance to market benchmark return within the same time period. The performance of stocks bought by Scott A. Kelly within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Scott A. Kelly's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Scott A. Kelly

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -7.04 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -14.99 LIMIT LIMIT LIMIT LIMIT LIMIT

Scott A. Kelly Ownership Network

Ownership Network List of Scott A. Kelly

No Data

Ownership Network Relation of Scott A. Kelly

Insider Network Chart

Scott A. Kelly Owned Company Details

What does CytoDyn Inc do?

Who are the key executives at CytoDyn Inc?

Scott A. Kelly is the director of CytoDyn Inc. Other key executives at CytoDyn Inc include EVP of Legal Affairs Tyler Blok , President Arvin Cyrus Arman , and Chief Financial Officer Antonio Migliarese .

CytoDyn Inc (CYDY) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of CytoDyn Inc (CYDY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of CytoDyn Inc (CYDY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

CytoDyn Inc (CYDY)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

CytoDyn Inc Insider Transactions

No Available Data

Scott A. Kelly Mailing Address

Above is the net worth, insider trading, and ownership report for Scott A. Kelly. You might contact Scott A. Kelly via mailing address: C/o Cytodyn Inc., 1111 Main Street, Suite 660, Vancouver Wa 98660.